The decision to build a heavy-ion accelerator in Japan dedicated to the treatment of cancer has been controversial: The facility was costly to build, and the therapy is still experimental.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nathan, R. Weighing the benefits of heavy-ion therapy. Nat Med 1, 606–607 (1995). https://doi.org/10.1038/nm0795-606
Issue Date:
DOI: https://doi.org/10.1038/nm0795-606